Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • China Feature Special

    - PMLiVE

    North East and North Cumbria NHS rolls out digital health platform to combat chronic kidney disease, affecting 1 in 10 UK adults

    In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria Integrated Care Board (ICB) has adopted the Healthinote digital health platform, providing...

    Healthinote (by Cognitant)

    - PMLiVE

    Bridging the gap in personalised digital support: My Stroke Companion

    To empower stroke survivors to engage with their care, Cognitant, in partnership with University College London Hospitals (UCLH), identified a need for a new digital health companion that can support...

    Healthinote (by Cognitant)

    - PMLiVE

    Kidney Research UK invests in Healthinote patient education platform which could support >15m people with long term health conditions

    Kidney Research UK, the leading charity dedicated to kidney health, has made a significant investment in Cognitant Group Ltd, a leading provider of digital education and support tools to improve...

    Healthinote (by Cognitant)

    - PMLiVE

    Health literacy & the creation of shared decision aids for patients with cancer

    In this blog, Gini Melesi, Head of Transformation, East of England Cancer Alliance, & Diane Whitney, Head of Brachytherapy Physics, Cambridge University Hospitals NHS Foundation Trust, explore the relationship between...

    Healthinote (by Cognitant)

    - PMLiVE

    From Noise to Impact: Why Simplicity Is The Health Communicator’s Most Powerful Tool

    Clear health communication has never been more critical, as shown by the 2025 surge in ADHD self-diagnoses in the UK, driven by misleading social media content. In a noisy, fast-paced...

    Fox&Cat

    - PMLiVE

    AstraZeneca announces $2.5bn investment in China to boost R&D capabilities

    The funds will go towards a new global research and development centre in Beijing’s BioPark

    - PMLiVE

    AstraZeneca to expand cell therapy capabilities with $1bn EsoBiotec acquisition

    The biotech’s ENaBL platform enables cell therapies to be administered through an IV injection

    - PMLiVE

    Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?

    By Manca Povsic and Andrew Dobb

    Amiculum

    - PMLiVE

    Stemming the Flow–Medscape Presents at HLTH Europe

    Medscape Education will be attending HLTH Europe from June 17-20. Be sure to drop by our booth to participate in our survey and enjoy exciting giveaways. Additionally, Dr. John Whyte,...

    Medscape Education

    - PMLiVE

    Navigating the rapidly changing oncology treatment landscape: how digital tools can help

    With rapid growth comes growing pains...

    Impetus Digital

    Mtech Access certified as a NICE META tool facilitating organisation

    Mtech Access are now a certified NICE META Tool facilitating organisation, with three experts having passed the NICE assessment

    Petauri Evidence

    - PMLiVE

    Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

    Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

    Avalere Health

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links